Emerging Strategies in Cancer Metabolism. Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids

1. Introduction to Gut Microbiota in Cancer Metabolism

2. Cancer Metabolic Rewiring of Reactive Oxygen Species

3. Emerging strategies in Cancer metabolism: Role of Gut microbiota, reactive oxygen species, and short chain fatty acids

4. Exploring the Link Between Gut Microbiome and Cancer: Metabolic Implications and Therapeutic Avenue

5. Oxidative Stress and Cancer Metabolism: From Pathogenesis to Therapeutic Opportunities

6. Targeting ROS Signaling Pathways for Cancer Metabolic Reprogramming

7. SCF Complex: Master Regulator of Metabolic Adaptations in Cancer Cells

8. Manipulating gut microbial metabolites for cancer therapy: A Metabolism-centric approach

9. Metabolic Crossroads: Integrating ROS, SCF and Gut Microbiota in Cancer

10. Therapeutic Advances: Modulating Gut Microbiota, ROS, and SCF Pathways in Cancer Treatment

11. Precision Medicine in Cancer Metabolism: Personalized Approaches Exploiting Metabolic Vulnerabilities

12. Novel Biomarkers and Therapeutic Targets: Harnessing Metabolic Insights for Improved Cancer Management

13. Future aspects: Novel Strategies in Cancer Metabolism Research and Clinical Interventions

14. Novel approach in Bridging the Gap between Cancer Biology and Metabolism

15. Implementing Gut Microbiota, ROS, and SCF Modulation in Cancer Care: Research into Practice

Descripción

Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids offers a comprehensive and interdisciplinary examination of the complex interactions linking cancer metabolism with gut microbiota, reactive oxygen species (ROS), and short chain fatty acid (SCF) dysregulation. Across 14 chapters, this book explores how metabolic alterations within cancer cells contribute to tumour survival and progression, presenting cutting-edge insights that reshape the understanding of cancer biology and therapeutic innovation.

This resource provides an in-depth analysis of the roles of gut microorganisms, oxidative stress mechanisms, and SCF pathways in the modulation of cancer metabolism—opening the door to novel targeted treatments and personalised therapeutic strategies. It is an essential reference for researchers in cancer biology, oncology, gut microbiology, and related biomedical fields.

• Creates new opportunities for focused therapies and patient-specific treatment plans by examining the roles of the gut microbiota, ROS, and SCF dysregulation in cancer metabolism
• Discusses in-vitro, ex-vivo, and animal models used to investigate the effects of probiotics and their metabolites in cancer care
• Focuses on cutting-edge research on probiotic-derived treatments in oncogene downregulation, autophagy induction, kinase inhibition, tumour suppressor reactivation, and metastasis prevention